Conestoga Capital Advisors, LLC Biodesix Inc Transaction History

Conestoga Capital Advisors, LLC

  • $7.22 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 21, 2022
SELL
$4.09 - $8.67 $470,861 - $998,133
-115,125 Closed
0 $0
Q3 2021

Oct 22, 2021
BUY
$6.6 - $12.78 $660 - $1,278
100 Added 0.09%
115,125 $946,000
Q2 2021

Jul 27, 2021
BUY
$12.14 - $20.35 $235,212 - $394,281
19,375 Added 20.26%
115,025 $1.52 Million
Q1 2021

Apr 23, 2021
BUY
$16.87 - $31.21 $316,312 - $585,187
18,750 Added 24.38%
95,650 $1.94 Million
Q4 2020

Jan 26, 2021
BUY
$10.89 - $20.16 $837,441 - $1.55 Million
76,900 New
76,900 $1.55 Million

Others Institutions Holding BDSX

# of Institutions
58
Shares Held
62.3M
Call Options Held
2.6K
Put Options Held
10.1K
View Full List

About BIODESIX INC

BDSX Quotes by TradingView
  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $59.2M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Conestoga Capital Advisors, LLC Portfolio

Follow Conestoga Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Conestoga Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Conestoga Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email